|
|
| Home >> Medical Zone > Betaglim |
|
|
|
 |
 |
|
|
| BETAGLIM |
| |
- Nidhi Bajpai, Ajit Pal Singh, Arani Chatterjee
A Nine Months Open Labelled, Multicentric, Non-comparative Study for Evaluation of Efficacy (Glycaemic Control), Safety and Tolerability of BetaglimTM in Type- 2 Diabetes
The present post marketing surveillance evaluated the efficacy, safety and tolerability of BetaglimTM (Glimepiride) in 558 patients with type 2 diabetes. It was an open labeled, non-comparative, multi centric study; which involved 35 investigators across the country. As per the doctors recording, the overall response to BetaglimTM was excellent to very good and the drug was reportedly well tolerated.
|
|
|
| |
|
